| Dr Kevin Allen Skidmore, OD | |
|
854 Ridgewood Drive, Berea, KY 40403 | |
| (859) 986-7027 | |
| (859) 986-4749 |
| Full Name | Dr Kevin Allen Skidmore |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 12 Years |
| Location | 854 Ridgewood Drive, Berea, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093060188 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | OPT.6159-THER (Ohio) | Secondary |
| 152W00000X | Optometrist | 1913DT (Kentucky) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dr. Gary E. King Optometrist Psc | 8628138229 | 5 |
News Archive
A collaborative effort led by The Burnham Institute's Gen-Sheng Feng has created a mouse with improved glucose tolerance and insulin activity in the liver, and generated new findings about insulin-signaling in the liver that could prove useful in understanding the pathogenesis of type 2 diabetes.
Telmisartan, an angiotensin receptor blocker, is one of the best researched drugs worldwide. It has been studied in clinical trials in more than 50,000 patients. Its positive safety profile has been confirmed also in a market exposure of 34.5 million patient years. Convincing safety data for patients with a high cardiovascular risk were collected in the three long-term outcome trials ONTARGET, PRoFESS and TRANSCEND which followed some of the patients for up to five years.
In a study recently published in Advanced Biomedical Engineering, researchers at Okayama University report a thin photoelectric film which can stimulate degenerated retinal tissues of the eye.
Oxis Biotech, Inc., a wholly owned subsidiary of Oxis International, Inc., announced today the execution of an exclusive worldwide license agreement to further develop and commercialize DT2219ARL, a novel therapy for the treatment of various human B cell cancers, leukemias and lymphomas.
› Verified 7 days ago
| Provider Name | Dr. Gary E. King Optometrist Psc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1588819080 PECOS PAC ID: 8628138229 Enrollment ID: O20081126000246 |
News Archive
A collaborative effort led by The Burnham Institute's Gen-Sheng Feng has created a mouse with improved glucose tolerance and insulin activity in the liver, and generated new findings about insulin-signaling in the liver that could prove useful in understanding the pathogenesis of type 2 diabetes.
Telmisartan, an angiotensin receptor blocker, is one of the best researched drugs worldwide. It has been studied in clinical trials in more than 50,000 patients. Its positive safety profile has been confirmed also in a market exposure of 34.5 million patient years. Convincing safety data for patients with a high cardiovascular risk were collected in the three long-term outcome trials ONTARGET, PRoFESS and TRANSCEND which followed some of the patients for up to five years.
In a study recently published in Advanced Biomedical Engineering, researchers at Okayama University report a thin photoelectric film which can stimulate degenerated retinal tissues of the eye.
Oxis Biotech, Inc., a wholly owned subsidiary of Oxis International, Inc., announced today the execution of an exclusive worldwide license agreement to further develop and commercialize DT2219ARL, a novel therapy for the treatment of various human B cell cancers, leukemias and lymphomas.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kevin Allen Skidmore, OD 854 Ridgewood Drive, Berea, KY 40403 Ph: (859) 986-7027 | Dr Kevin Allen Skidmore, OD 854 Ridgewood Drive, Berea, KY 40403 Ph: (859) 986-7027 |
News Archive
A collaborative effort led by The Burnham Institute's Gen-Sheng Feng has created a mouse with improved glucose tolerance and insulin activity in the liver, and generated new findings about insulin-signaling in the liver that could prove useful in understanding the pathogenesis of type 2 diabetes.
Telmisartan, an angiotensin receptor blocker, is one of the best researched drugs worldwide. It has been studied in clinical trials in more than 50,000 patients. Its positive safety profile has been confirmed also in a market exposure of 34.5 million patient years. Convincing safety data for patients with a high cardiovascular risk were collected in the three long-term outcome trials ONTARGET, PRoFESS and TRANSCEND which followed some of the patients for up to five years.
In a study recently published in Advanced Biomedical Engineering, researchers at Okayama University report a thin photoelectric film which can stimulate degenerated retinal tissues of the eye.
Oxis Biotech, Inc., a wholly owned subsidiary of Oxis International, Inc., announced today the execution of an exclusive worldwide license agreement to further develop and commercialize DT2219ARL, a novel therapy for the treatment of various human B cell cancers, leukemias and lymphomas.
› Verified 7 days ago
M Andrew Durant Od Pllc Optometrist Medicare: Medicare Enrolled Practice Location: 116 Mini Mall Dr, Berea, KY 40403 Phone: 859-985-0078 Fax: 859-985-0045 | |
Dr. Gary E King, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 854 Ridgewood Dr., Berea, KY 40403 Phone: 859-986-7027 Fax: 859-986-4749 | |
Central Kentucky Eye Care Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 120 Jill Dr, Berea, KY 40403 Phone: 859-985-8641 Fax: 859-985-8867 | |
Dr. Sarah Kaitlin King, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 854 Ridgewood Dr., Berea, KY 40403 Phone: 859-986-7027 Fax: 859-986-4749 | |
Flying Eye Pllc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 305 Estill St Fl 4, Berea, KY 40403 Phone: 606-666-9393 Fax: 606-666-4131 | |
Jason B. Howard, O.d. L.l.c. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 120 Jill Dr, Berea, KY 40403 Phone: 859-986-3759 |